Wikidata

(Q65379491)

English

A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.

clinical trial

In more languages

Statements

title
A Randomized, Open Label Study to Compare the Complete Pathological Response Rate Achieved With 4 Combinations of Herceptin, Docetaxel and Pertuzumab in Patients With Locally Advanced, Inflammatory or Early Stage HER2 Positive Breast Cancer (English)
0 references
sponsor
Hoffmann-La Roche
0 references
country
Australia
0 references
Austria
0 references
Brazil
0 references
Canada
0 references
Israel
0 references
Italy
0 references
Mexico
0 references
Peru
0 references
Poland
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
Taiwan
0 references
Thailand
0 references
Turkey
0 references
United Kingdom
0 references
start time
26 June 2006
0 references
end time
22 September 2014
0 references
number of participants
417
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65379491&oldid=1982617242"